QMS Medical Allied Services Limited — Important, 14-11-2024: Financial Result Updates

**QMS Medical Allied Services Limited – Financial Summary**

Consolidated total income for the quarter ended September 30, 2024, stood at ₹3,75,266 Cr, reflecting a substantial increase from ₹2,87,572 Cr for the same period last year, which translates to a revenue growth of approximately 30%. The growth can be attributed to an increase in operational efficiency and market expansion efforts.

Net profit for the quarter rose to ₹30,305 Cr, compared to ₹25,601 Cr in the previous year, marking a year-over-year increase of around 18%. Earnings Per Share (EPS) for this quarter stands at ₹19.3, up from ₹15.4, highlighting improved profitability driven by better cost management and operational performance.

Total expenses increased to ₹3,18,635 Cr from ₹2,83,400 Cr, primarily due to higher purchase costs and employee benefits expenses. Here, the company has managed operational costs effectively, with employee expenses rising but being offset by lower depreciation expenses, indicating strengthened operational efficiency.

On the balance sheet, shareholder equity increased to ₹6,649.78 Cr at the end of September 2024 from ₹6,066.38 Cr in March 2024. Cash flow from operating activities reflects strong performance at ₹1,694.75 Cr, up from ₹467.38 Cr in the prior year, indicating healthy cash generation for the company.

Looking ahead, the company’s strategic focus on enhancing operational efficiencies and expanding its market presence bodes well for future growth. Based on this quarter's performance and continued cost management, a buy insight is suggested for investors considering long-term gains.